1965
DOI: 10.1055/s-0028-1113357
|View full text |Cite
|
Sign up to set email alerts
|

Folgen am harnbereitenden und harnableitenden System während Cyclophosphamid-Therapie1

Abstract: Frauenklinik Tübingen konnten nach der Verwendung von Cyclophosphamid (Endoxan®) ,, Endoxan-Zystitiden" ver-Hofrat Professor Dr. W. Dick zum 65. Geburtstag. schiedener Schweregrade beobachtet werden. Folgende Einteilung wird vorgeschlagen: Grad: Miktionsbeschwerden bei gering pathologischem Urinbefund (Erythrozyten, Leukozyten) ohne Makrohämaturie. Zystoskopisch: fleckförmige oder diffuse Rötung. Diagnose: katarrhalische bzw. geringe hämorrhagische Zystitis. Grad: Makrohämaturie mit deutlich pathologischem Uri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1970
1970
1988
1988

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Published data on the incidence of bladder toxicity associated with pelvic irradiation and cyclophosphamide in combination are scanty in adults and are not available for children. Spechter et al 13 hematuria in patients who received pelvic irradiation and cyclophosphamide; six of these cases were fatal. Accinelli' noted bladder toxicity in nine patients of a n unstated denominator who received the two agents in combination.…”
Section: Discussionmentioning
confidence: 99%
“…Published data on the incidence of bladder toxicity associated with pelvic irradiation and cyclophosphamide in combination are scanty in adults and are not available for children. Spechter et al 13 hematuria in patients who received pelvic irradiation and cyclophosphamide; six of these cases were fatal. Accinelli' noted bladder toxicity in nine patients of a n unstated denominator who received the two agents in combination.…”
Section: Discussionmentioning
confidence: 99%
“…Urological complications due to its administration are well documented following the initial reports of transient cystitis by Coggins, Randin and Eisman (1959). As well as haemorrhagic cystitis which may be fatal (Spechter et al, 1965), widespread interstitial fibrosis may follow long-term administration (Johnson and Meadows, 1961 ;Marsh et al, 1971). Damage to the urinary tract caused by cyclophosphamide is due to direct contact between urothelium and toxic metabolites of cyclophosphamide excreted in the urine (Phillips et al, 1961).…”
mentioning
confidence: 99%